hkr.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Efficiency of cross-bridges and mitochondria in mouse cardiac muscle
Griffith University, Gold Coast, QLD, Australia.
Sveriges lantbruksuniversitet, Kristianstad.ORCID-id: 0000-0001-8602-6524
2010 (engelsk)Inngår i: Muscle biophysics: from molecules to cells / [ed] D.E. Rassier, Springer Berlin/Heidelberg, 2010, Vol. 682, s. 267-278Kapittel i bok, del av antologi (Fagfellevurdert)
Abstract [en]

The aim of this study was to make cellular-level measurements of the mechanical efficiency of mouse cardiac muscle and to use these measurements to determine (1) the work performed by a cross-bridge in one ATP-splitting cycle and (2) the fraction of the free energy available in metabolic substrates that is transferred by oxidative phosphorylation to free energy in ATP (i.e. mitochondrial thermodynamic efficiency). Experiments were performed using isolated left ventricular mouse papillary muscles (n = 9; studied at 27°C) and the myothermic technique. The production of work and heat was measured during and after 40 contractions at a contraction frequency of 2 Hz. Each contraction consisted of a brief isometric period followed by isovelocity shortening. Work output, heat output and enthalpy output were all independent of shortening velocity. Maximum initial mechanical efficiency (mean ± SEM) was 31.1 ± 1.3% and maximum net mechanical efficiency 16.9 ± 1.5%. It was calculated that the maximum work per cross-bridge cycle was 20 zJ, comparable to values for mouse skeletal muscle, and that mitochondrial thermodynamic efficiency was 72%. Analysis of data in the literature suggests that mitochondrial efficiency of cardiac muscle from other species is also likely to be between 70 and 80%.

sted, utgiver, år, opplag, sider
Springer Berlin/Heidelberg, 2010. Vol. 682, s. 267-278
Serie
Advances in Experimental Medicine and Biology ; 682
HSV kategori
Identifikatorer
URN: urn:nbn:se:hkr:diva-13422DOI: 10.1007/978-1-4419-6366-6_15ISI: 000282384000015PubMedID: 20824531ISBN: 978-1-4419-6365-9 (tryckt)ISBN: 978-1-4419-6366-6 (tryckt)OAI: oai:DiVA.org:hkr-13422DiVA, id: diva2:782299
Tilgjengelig fra: 2015-01-20 Laget: 2015-01-20 Sist oppdatert: 2015-01-20bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMed

Person

Widén, Cecilia

Søk i DiVA

Av forfatter/redaktør
Widén, Cecilia

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
isbn
urn-nbn

Altmetric

doi
pubmed
isbn
urn-nbn
Totalt: 56 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf